Rare
lephants
Screener
Toggle theme
ANI PHARMACEUTICALS, INC
ANIP
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
Total Cash from Operations:
$27.2M
Line Item
Value
% of Total
Capital Expenditures
$2.2M
8.0%
Other Investing
$16.1M
59.4%
Working Capital
$8.9M
32.6%
Net Cash Flow
$0
0.0%
